Document is current
Any future updates will be listed below
-
Authors
Andreu-Bernabeu, Álvaro
Díaz-Caneja, Covadonga M. https://orcid.org/0000-0001-8538-3175
Costas, Javier
De Hoyos, Lucía https://orcid.org/0000-0001-7252-1591
Stella, Carol
Gurriarán, Xaquín
Alloza, Clara
Fañanás, Lourdes https://orcid.org/0000-0001-6266-7706
Bobes, Julio https://orcid.org/0000-0003-2187-4033
González-Pinto, Ana
Crespo-Facorro, Benedicto
Martorell, Lourdes
Vilella, Elisabet https://orcid.org/0000-0002-1887-5919
Muntané, Gerard
Nacher, Juan
Molto, María Dolores
Aguilar, Eduardo Jesús https://orcid.org/0000-0002-7875-5644
Parellada, Mara
Arango, Celso https://orcid.org/0000-0003-3382-4754
González-Peñas, Javier https://orcid.org/0000-0002-3850-3012
- License Information
-
More Information
Article History
Received: 18 December 2020
Accepted: 26 November 2021
First Online: 10 January 2022
Competing interests
: C.A has been a consultant to or has received honoraria or grants from Acadia, Angelini, Gedeon Richter, Janssen Cilag, Lundbeck, Minerva, Otsuka, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion, and Takeda. B.C.-F. has received honoraria (advisory board and educational lectures) and travel expenses from Takeda, Menarini, Angelini, Teva, Otsuka, Lundbeck, and Johnson & Johnson. He has also received unrestricted research grants from Lundbeck. Xaquín Gurriarán has received a grant from Fundación Instituto Roche. C.M.D.-C. has received honoraria from AbbVie, Sanofi, and Exeltis. The rest of the authors declare no competing interests.
